Riley Rose
Acute Care · Marion, INNPI 1356776918
Payments from drug & device makers
Across 24 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$103
- Boston Scientific$69
- Tactile Systems Technology Inc$58
- Paratek Pharmaceuticals, Inc.$57
- Smith+Nephew$41
- Integra Lifesciences Corporation$37
- plus $164 from 6 others
What the payments were for
- Food & beverage$528100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 5 | $103 |
| Boston Scientific | 1 | $69 |
| Tactile Systems Technology Inc | 3 | $58 |
| Paratek Pharmaceuticals, Inc. | 3 | $57 |
| Smith+Nephew | 2 | $41 |
| Integra Lifesciences Corporation | 2 | $37 |
| Kerecis Limited | 1 | $35 |
| Convatec Inc. | 2 | $35 |
| Hartmann USA, Inc. | 2 | $34 |
| Medline Industries LP | 1 | $22 |
| KCI USA, Inc. | 1 | $20 |
| Aroa Biosurgery Incorporated | 1 | $19 |
How this compares
$528 in reported general payments places this provider in the 55th percentile of 240 acute care providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 109 | $23,146 |
| JardianceEmpagliflozin | 98 | $14,726 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 295 | $4,461 |
| TradjentaLinagliptin | 32 | $4,070 |
| Tramadol Hcl | 170 | $1,854 |
| Gabapentin | 229 | $1,670 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 62 | $1,538 |
| LantusInsulin Glargine,hum.Rec.Anlog | 20 | $1,491 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 62 | $1,363 |
| Midodrine Hcl | 30 | $1,311 |
| Lisinopril | 213 | $1,266 |
| Oxycodone Hcl | 33 | $1,218 |
| Atorvastatin Calcium | 200 | $1,173 |
| Doxycycline Hyclate | 82 | $1,039 |
| Torsemide | 137 | $988 |
Paid to pharmacies, not to this prescriber.
Other acute care in Marion
- Melissa LorenzJeffersonville$19K
- Amara Wright-TerryMunster$17K
- Wen CaiNewburgh$12K
- Erin BarthSouth Bend$10K
- Sarah LongNewburgh$8K
- Aaron HoldermanNewburgh$8K
- Lauren ArmingtonIndianapolis$7K
- Ashley HillIndianapolis$7K
- Sara RichesonNewburgh$6K
- Sarah KachmanTerre Haute$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.